Pharmacoepidemiology and Drug Safety

Article	Citations
	109
Issue Information	72
Letter to the Editor	52
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second‐Line Treatment of Advanced Non–Small Cell Lung Cancer	51
Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research	41
External validity in distributed data networks	37
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–2018	35
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain”	35
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review	34
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark	34
Issue Information	34
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries	33
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data	32
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review	26
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems	25
ORAL PRESENTATION	25
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries	24
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study	23
Causal Forests Versus Inverse Probability of Treatment Weighting to Adjust for Cluster‐Level Confounding: A Parametric and Plasmode Simulation Study Based on US	23
Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis	22
Data Resource Profile: The Danish National Hospital Medicine Register	21
Issue Information	21
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+	21
Issue Information	19
All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator Arm	19

	19
Comorbidity influence in observational studies: Why ignore the real world?	18
Use of gastrointestinal prokinetics and the risk of parkinsonism: A population‐based case‐crossover study	18
Comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug–drug interactions	18
Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis	16
Validation of a Major and Clinically Relevant Nonmajor Bleeding Phenotyping Algorithm on Electronic Health Records	16
Trends in the Dispensing of Oral Anti‐Cancer Medications Across Australia Over 10 Years	16
	15
Prenatal and Early‐Life Anti‐Infectives and Obesity at Age 7 Years	15
	15
Corrigendum to “A Brief Report on Proposed Areas of International Harmonization of Real‐World Evidence Relevance, Reliability and Quality Standards Among Medical Product Regulators”	14
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases	14
Overlap Weights for Binary Outcomes: A Performance Assessment	14
Valproate utilisation trends among women of childbearing potential in Ireland between 2014 and 2019: A drug utilisation study using interrupted time series	14
Comparing survival in trial‐ versus routine‐care advanced urothelial cancer patients on immune checkpoint blockade	14
Validity of ICD‐10‐based algorithms to identify patients with influenza in inpatient and outpatient settings	13
Federated analyses of multiple data sources in drug safety studies	13
Titel: Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study	13
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe	13
Impact of Lookback Duration on the Performance of a Claims‐Based Frailty Proxy in Women With Stage I–III Breast Cancer	13
Advancing Research Transparency and Reproducibility in Pharmacoepidemiology	13
Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databases	13
Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke	13
Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis	12
An individual segmented trajectory approach for identifying opioid use patterns using longitudinal dispensing data	12
Validation of alopecia coding in US claims data among women of childbearing age	12
An Emulated Target Trial Case Study of Real‐World Overall Survival With Second‐Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer	12
Probabilistic precision calculations for the planning of studies assessing negative binomial rates	12
Issue Information	12
Hypertension medication from guidelines to practice: A cohort study in western Iran	12
Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real‐world data source on medication use in pregnancy in Belgium	12
Hazard Ratios and Alternative Effect Measures: An Applied Illustration	12
Issue Information	11
Validation of an algorithm to identify fractures among patients within the Veterans Health Administration	11
Safety of BNT162b2 mRNA COVID ‐19 Vaccine Batches: A Nationwide Cohort Study	11
Issue Information	11
The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths	11
Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community	11
Review of Mother–Infant Linkage Algorithms in Health Care Data Sources	11
Clozapine‐Associated Neutropenia Prevalence in a Large, Integrated Healthcare System	11
Assessing medical product safety during pregnancy using parameterizable tools in the sentinel distributed database	11
Post‐Market Evidence for Cancer Medicines in Regulatory and Clinical Decision‐Making: A Scoping Review	11
The European Drug–Drug Interaction (EuroDDI) Study Protocol: A Cross‐Country Comparison of Drug–Drug Interaction Prevalence in the Older Community‐Dwelling Population	11
Development and validation of an electronic health records‐based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids	11
Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation	11
Recommendations to Enable Broader Use of Real‐World Evidence to Inform Decision‐Making Throughout Pharmacovigilance Signal Management	11
Consistency between the National Patient Register and the Swedish Cancer Register	10
Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes	10
Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned	10
Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large‐scale COVID‐19 surveillance system	10

Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus	10
Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong	10
Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe	10
Characterization of SARS‐CoV‐2 Diagnostic Tests and Liver Function Tests Among Patients With COVID‐19 Diagnosed in Outpatient Settings Using Administrative Healthcare	10
Issue Information	10
Glucagon‐like Peptide‐1 Receptor Agonists in Asthma Exacerbations: An Application of High‐Dimensional Iterative Causal Forest to Identify Subgroups	10
The risk of miscarriage after COVID‐19 vaccination before and during pregnancy	9
Valproic Acid‐Induced Congenital Disorders, an Analysis in EudraVigilance and a Literature Review of Valproic Acid Utilization During Pregnancy	9
Issue Information	9
Association between pre‐admission anticoagulation and in‐hospital death, venous thromboembolism, and major bleeding among hospitalized COVID‐19 patients in Japan	9
Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications	9
Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations	9
Effectiveness and Safety of Reduced and Standard Initial Doses of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Retrospective Study in Taiwan	9
10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology	9
Issue Information	8
ABSTRACTS of the 2024 ISPE Annual Meeting, Berlin, Germany, 24–28 August 2024	8
Association of Quinolone Exposure in the First‐Trimester of Pregnancy and the Risk of Major Congenital Malformations: A Health Administrative Database Study in Japan	8
Validation Assessment of Privacy‐Preserving Synthetic Electronic Health Record Data: Comparison of Original Versus Synthetic Data on Real‐World COVID‐19 Vaccine Effectiveness	8
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing data	8
Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies	8
ISPE20 Author Index	8
A meta‐analysis assessing the prevalence of drug–drug interactions among hospitalized patients	8
Trends in clomiphene citrate and gonadotropins use in women with infertility between 2010 and 2017: A population‐based study in France	8
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID ‐19 vaccine safety surveillance: Incidence between	8
TriNetX Dataworks‐ USA : Overview of a Multi‐Purpose, De‐Identified, Federated Electronic Health Record Real‐World Dat	8
Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries	8
A drug utilization study of thiocolchicoside‐containing medicinal products for systemic use in France and Italy: A cross‐sectional electronic medical records database study	8
Sex‐specific incidence of hepatitis B virus flares among Bcr‐Abl tyrosine kinase inhibitor users in Taiwan	8
Detecting and Dating Early Non‐live Pregnancy Outcomes: Generation of a Novel Pregnancy Algorithm From Norwegian Linked Health Registries	8
The Reporting and Methodological Recommendations for Observational Studies Estimating the Effects of Deprescribing Medications (REMROSE‐D) ISPE‐Endorsed Guidance	8
Dipeptidyl Peptidase‐4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus and End‐Stage Renal Disease Requiring Dialysis	8
Comparison of record linkage software for deduplicating patient identities in California's Prescription Drug Monitoring Program	7
A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in ty	7
	7
	7
Prevalence of Polypharmacy in Elderly Population Worldwide: A Systematic Review and Meta‐Analysis	7
	7
Core Concepts in Pharmacoepidemiology: Principled Use of Artificial Intelligence and Machine Learning in Pharmacoepidemiology and Healthcare Research	7
Patterns of filled prescriptions and the association with risk of drug‐induced death. A population‐based nested case‐control register study	7
Accuracy and validity of reported opioid prescription days' supply	7
Comparative Safety of Glucagon‐Like Peptide 1 Receptor Agonists ( GLP ‐1‐ RAs ) in Type 2 Diabetes	7
Adverse drug reaction signal detection methods in spontaneous reporting system: A systematic review	7
Issue Information	7
The Effects of Removing the Requirement for Prior Reimbursement Approval on Anticoagulant Use in Ireland: A Cross‐Sectional Study	7
Signal detection of COVID‐19 vaccines adverse events using spontaneous reports from South Korea	7
Development and Validation of Claims‐Based Algorithms for Conjunctivitis and Keratitis	7
Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System	7
Issue Information	7
Corrigendum	7
Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan	6
Opioid tapering and mental health crisis in older adults	6
Risk of Ischaemic Stroke Varies With Antithrombotic Drugs Use in Proton Pump Inhibitor Users: A Self‐Controlled Case Series Study	6
Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events	6
Core Concepts: Self‐Controlled Designs in Pharmacoepidemiology	6
Opioid Use After Hip Fracture and Subsequent Fracture Outcomes: A Self‐Controlled Case Series Design	6
Prescribing of valproate and oral antiepileptics for women of childbearing age and during pregnancy in Germany between 2010 and 2020	6
Preregistration: A Key to Credible Real‐World Evidence Generation	6
	6
The Effect of Isoniazid for Tuberculosis Prevention on Pregnancy Risk Among Women Living With HIV on Antiretroviral Treatment and Progestin‐Based Hormonal Contraception	6
Rescheduling gabapentinoids had negligible effects on prescribing behaviour by general practitioners in England	6
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data	6
SUPPLEMENTARY ABSTRACTS of ICPE 2021, the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 23–25 August, 2021 (virtual)	6
Real‐World Use of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis in the United States: Persistence, Variables Associated With Persistenc	6
Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case–control study designs	5
Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy	5
Validation studies of Japanese administrative health care data: A scoping review	5
Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase	5
The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark	5
Real world prescription of beta‐blockers in patients with asthma	5
Examining the potential direct cardiovascular benefit of tumor‐necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses	5
The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures	5
Mobile apps for quick adverse drug reaction report: A scoping review	5
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?	5
ABSTRACTS of the virtual 2nd Annual African Regional Interest Group Meeting (AfRIG), 11–13 July, 2022	5
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain	5
Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of Extended‐Release Oxycodone on Tampering in a Real‐World Settings	5
	5
Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis	5
Issue Information	5
Issue Information	5

Sampling in the case‐time‐control design among drug users when outcome prevents further treatment	5
Comparing IPCW Models to Adjust for Informative Censoring During COVID ‐19 Using Data From the Cli	5
Epidemiological Profile of Exogenous Intoxications by Self‐Medication in Brazil: A Decade of Trends and the Impact of the COVID ‐19	5
Real‐world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy	5
	5
Overview of global real‐world data sources for pediatric pharmacoepidemiologic research	5
INSIGHT : A Tool for Fit‐for‐Purpose Evaluation and Quality Assessment of Standardized Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety	5
Prevalence of self‐medication practices among pregnant women in India: A systematic review and meta‐analysis	5
Severe Cutaneous Adverse Reactions in Hospitalized Children: A Pilot Validation Study	5
Correction to “A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data”	5
To wait or not to wait: Weighing the pros and cons of early identification of safety concerns for medications used in pregnancy	5
Mapping Use of High Dose or Long‐Term Oral Glucocorticoids and Steroid‐Sparing Strategies in Adults With Chronic Conditions: A Rapid Scoping Review of Reviews	5
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis	5
Association of Benzodiazepine Prescription With Short‐Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT	5
Kidney function and prescribed dose in middle‐aged and older patients starting selective serotonin reuptake inhibitors	5
Validation of an algorithm for identifying incident cancer cases based on long‐term illness and diagnosis related group program data from the French National Health Insurance Informati	4
Myopericarditis following COVID‐19 mRNA vaccination	4
Validity of claims data for identifying cancer incidence in the Japan public health center‐based prospective study for the next generation	4
The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia	4
Strengthening Pharmacoepidemiology in a Changing Research Environment: The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance ( ENCePP	4
Increasing Prevalence of Long‐Term Antidepressant Use in Australia: A Retrospective Observational Study	4
Achieving comparability in glycemic control between antidiabetic treatment strategies in pregnancy when using real world data	4
Development of a multivariate prediction model to identify individual case safety reports which require clinical review	4
Evaluating the Impact of Data Standardization on Real‐World Data	4
A Two‐Step Framework for Validating Causal Effect Estimates	4
Current Use of Common Data Models in the Nordic Countries	4
Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real‐world data	4
Issue Information	4
Issue Information	4
Prescriber Adherence to Antihypertensive Prescription Guidelines and the Impact of Patient Socioeconomic Factors: A Cross‐Sectional Study Using Data From the Irish Longitudinal Study on Ageing	4
Issue Information	4
Pain‐related hospitalization and emergency room visit following initial analgesic prescription after outpatient surgery	4
Hydrochlorothiazide Use and Risk of Skin Cancer: A Population‐Based Retrospective Cohort Study	4
Development and Application of an Algorithm for Statin‐Induced Myopathy Based on Electronic Health Record‐Derived Structured Elements	4
Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997–2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014–2018)	4
More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching	4
Correction to “An Open‐Source Implementation of Tree‐Based Scan Statistics”	4
Validation of ICD‐10 Diagnosis Codes for Identification of Acute Myocardial Infarction From a US Integrated Healthcare System	4
Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studies	4
Comparative Effectiveness and Safety of Torsemide Versus Furosemide in Older Adults With Heart Failure	4
STUDENT ABSTRACTS of ISPE's 2024 Mid‐Year Meeting, Orlando, Florida, USA, 14–16 April 2024	4
	4
Impact on In‐ and Out‐of‐Hospital Drug Prescriptions of Including a More Expensive Me‐Too Antidepressant in a Hospital Drug Formulary: a Controlled Longitudinal Study	4
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49–64 and 65–70 years old	4
Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program	4
Diagnostic Performance of Prostate Cancer Disease‐Specific Phenotypes Identified Using Real‐World Databases: A Systematic Review	4
Impact and Effectiveness of COVID ‐19 mRNA Vaccination Against COVID	4
Implementation of risk minimization measures to reduce the risk of tuberculosis among tumor necrosis factor medication users	4
Clarifying the causal contrast: An empirical example applying the prevalent new user study design	4
Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment	4
Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy	4
Antidepressant Use Trajectories and Risk of Discontinuation After Adolescents and Young Adult Cancer Diagnosis	4
Stratified analysis in comparative effectiveness studies that emulate randomized trials	4
Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation	4
Moxifloxacin monotherapy for treatment of uncomplicated pelvic inflammatory disease: A systematic review and meta‐analysis with trial sequential analysis of randomized controlled trials	4
	3
A Real‐World Pharmacovigilance Study of FDA Adverse Event Reporting System Events for Obeticholic Acid	3
	3
Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Pre	3
Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates to the National Death Index (NDI)	3
ISPE AfRIG Conference—Abstracts for PDS Publication, June 10–14, 2024, Mombasa, Kenya	3
Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database	3
Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community‐dwelling older patients acutely admitted to hospital? A Norwegian registry‐based	3
An algorithm‐based approach to ascertain patients with rare diseases in electronic health records using hypereosinophilic syndrome as an example	3
Issue Information	3
An observational post‐authorization safety study (PASS) of naloxegol drug utilization in four European countries	3
Vancomycin‐Induced Acute Kidney Injury in Intensive Care Patients: A Target Trial Emulation Study Using Multicenter Routinely Collected Data	3
Adherence and persistence of HIV pre‐exposure prophylaxis use in the United States	3
A European, Observational, 3‐Year Cohort Comparative Study on the Safety of the Fixed Dose Combination Pravastatin 40 mg/Fenofibrate 160 mg vs. Statin Alone in Real Clinical Practice: The POSE	3
Design considerations for observational studies of drugs for advanced cancer	3
Role of private prescriptions in the long‐term use of benzodiazepines and Z‐drugs: A patient‐related follow‐up study	3
Issue Information	3
	3
Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA‐2 trial	3
Very high PD‐L1 expression as a prognostic indicator of overall survival among patients with advanced non‐small cell lung cancer receiving anti‐PD‐(L)1 monotherapies i	3
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach	3
Multiple Perspectives on the Need for Real‐World Evidence to Inform Regulatory and Health Technology Assessment Decision‐Making: Scoping Review and Stakeholder Interviews	3
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe	3
Issue Information	3
Identification of risk factors for adverse drug reactions in a pharmacovigilance database	3
A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug–Drug Interactions in Women With Epilepsy	3
Application of multiple validated algorithms for identifying incident breast cancer among individuals with atopic dermatitis	3
Adverse Events Associated With Dabrafenib, Trametinib, and Their Combination Therapy: A Disproportionality Analysis of the FDA Adverse Event Reportin	3
A Comparative Real‐World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelina	3
Statin persistence and adherence among older initiators: A nationwide cohort study using the national health insurance claims database in Japan	3
Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post‐marketing surveillance	3
MetaLAB‐HOI: Template standardization of health outcomes enable massive and accurate detection of adverse drug reactions from electronic health records	3
Accuracy of administrative claims prescription fill data to estimate glucocorticoid use and dose in patients with rheumatoid arthritis	3
Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using Merative MarketScan Research Databases	3
Artificial intelligence in pharmacovigilance: Do we need explainability?	3
Combining Super Learner with high‐dimensional propensity score to improve confounding adjustment: A real‐world application in chronic lymphocytic leukemia	3
Corrigendum to “Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden – a population‐based register study”	3
Effectiveness of Baricitinib Risk Minimization Activities in Patients With Rheumatoid Arthritis—A Cohort Study in Four Nordic Countries	3
Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi‐stakeholder cross‐sec	3
Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review	3